IPCA-METOPROLOL metoprolol tartrate 50mg tablet blister pack Australië - Engels - Department of Health (Therapeutic Goods Administration)

ipca-metoprolol metoprolol tartrate 50mg tablet blister pack

ipca pharma (australia) pty ltd - metoprolol tartrate, quantity: 50 mg - tablet, film coated - excipient ingredients: colloidal anhydrous silica; lactose monohydrate; hypromellose; magnesium stearate; iron oxide red; croscarmellose sodium; macrogol 400; microcrystalline cellulose; sodium starch glycollate; titanium dioxide; purified talc; pregelatinised maize starch - hypertension: as monotherapy or for use in combination with other antihypertensives.,angina pectoris: for long-term prophylaxis. glyceryl trinitrate should be employed if necessary for alleviating acute attacks.,confirmed or suspected myocardial infarction.,prevention of migraine.

IPCA-TRAMADOL tramadol hydrochloride 50mg capsule blister pack Australië - Engels - Department of Health (Therapeutic Goods Administration)

ipca-tramadol tramadol hydrochloride 50mg capsule blister pack

ipca pharma (australia) pty ltd - tramadol hydrochloride, quantity: 50 mg - capsule - excipient ingredients: microcrystalline cellulose; iron oxide yellow; indigo carmine aluminium lake; gelatin; methyl hydroxybenzoate; sodium lauryl sulfate; titanium dioxide; magnesium stearate; propyl hydroxybenzoate; sodium starch glycollate; colloidal anhydrous silica - for the short-term management of severe pain for which other treatment options have failed, are contraindicated, not tolerated or are otherwise inappropriate to provide sufficient management of pain.

Ipca-ONDANSETRON TABLETS ondansetron (as hydrochloride dihydrate) 4 mg tablets blister pack Australië - Engels - Department of Health (Therapeutic Goods Administration)

ipca-ondansetron tablets ondansetron (as hydrochloride dihydrate) 4 mg tablets blister pack

ipca pharma (australia) pty ltd - ondansetron hydrochloride dihydrate, quantity: 5 mg (equivalent: ondansetron, qty 4 mg) - tablet - excipient ingredients: lactose; microcrystalline cellulose; pregelatinised maize starch; magnesium stearate; hypromellose; titanium dioxide; iron oxide yellow - ondansetron is indicated for the prevention and treatment of nausea and vomiting induced by cytotoxic therapy and radiotherapy.

Ipca-ONDANSETRON TABLETS ondansetron (as hydrochloride dihydrate) 8 mg tablets blister pack Australië - Engels - Department of Health (Therapeutic Goods Administration)

ipca-ondansetron tablets ondansetron (as hydrochloride dihydrate) 8 mg tablets blister pack

ipca pharma (australia) pty ltd - ondansetron hydrochloride dihydrate, quantity: 10 mg (equivalent: ondansetron, qty 8 mg) - tablet - excipient ingredients: lactose; microcrystalline cellulose; pregelatinised maize starch; magnesium stearate; hypromellose; titanium dioxide; iron oxide yellow - ondansetron is indicated for the prevention and treatment of nausea and vomiting induced by cytotoxic therapy and radiotherapy.

IPCA-ONDANSETRON ODT ondansetron 4 mg orally disintegrating tablet blister pack Australië - Engels - Department of Health (Therapeutic Goods Administration)

ipca-ondansetron odt ondansetron 4 mg orally disintegrating tablet blister pack

ipca pharma (australia) pty ltd - ondansetron, quantity: 4 mg - tablet, orally disintegrating - excipient ingredients: crospovidone; mannitol; silicified microcrystalline cellulose; magnesium stearate; microcrystalline cellulose; colloidal anhydrous silica; aspartame; flavour - ondansetron is indicated for the prevention and treatment of nausea and vomiting induced by cytotoxic therapy and radiotherapy.

IPCA-ONDANSETRON ODT ondansetron  8 mg orally disintegrating tablet blister pack Australië - Engels - Department of Health (Therapeutic Goods Administration)

ipca-ondansetron odt ondansetron 8 mg orally disintegrating tablet blister pack

ipca pharma (australia) pty ltd - ondansetron, quantity: 8 mg - tablet, orally disintegrating - excipient ingredients: silicified microcrystalline cellulose; magnesium stearate; crospovidone; microcrystalline cellulose; mannitol; aspartame; colloidal anhydrous silica; flavour - ondansetron is indicated for the prevention and treatment of nausea and vomiting induced by cytotoxic therapy and radiotherapy.

IPCA-PARACETAMOL paracetamol 500 mg film coated tablet bottle Australië - Engels - Department of Health (Therapeutic Goods Administration)

ipca-paracetamol paracetamol 500 mg film coated tablet bottle

ipca pharma (australia) pty ltd - paracetamol, quantity: 500 mg - tablet, film coated - excipient ingredients: macrogol 6000; propylene glycol; purified talc; titanium dioxide; hypromellose; magnesium stearate; pregelatinised maize starch - temporary relief of pain associated with headache, migraine headache, neuralgia, muscular aches and pains, cold and flu symptoms, arthritis, osteoarthritis, toothache, sore throat, period pain, rheumatic pain. reduces fever.

IPCA-PROCHLORPERAZINE prochlorperazine maleate 5 mg tablet blister pack Australië - Engels - Department of Health (Therapeutic Goods Administration)

ipca-prochlorperazine prochlorperazine maleate 5 mg tablet blister pack

ipca pharma (australia) pty ltd - prochlorperazine maleate, quantity: 5 mg - tablet - excipient ingredients: lactose monohydrate; maize starch; purified water; colloidal anhydrous silica; magnesium stearate - nausea and vomiting due to various causes including migraine; vertigo due to meniere's syndrome, labyrinthitis and other causes.

IPCA-PARACETAMOL 500 mg film coated capsule shaped tablet blister pack (new formulation) Australië - Engels - Department of Health (Therapeutic Goods Administration)

ipca-paracetamol 500 mg film coated capsule shaped tablet blister pack (new formulation)

ipca pharma (australia) pty ltd - paracetamol, quantity: 500 mg - tablet, film coated - excipient ingredients: hypromellose; propylene glycol; titanium dioxide; pregelatinised maize starch; macrogol 6000; magnesium stearate; purified talc - temporary relief of pain associated with headache, migraine headache, tension headache, sinus pain, toothache, dental procedures, backache, muscular aches and pains, arthritis, osteoarthritis, rheumatic pain, period pain, fibrositis, neuralgia, sore throat, tennis elbow, and colds and flu. reduces fever.

Ipca-Escitalopram Tablets Nieuw-Zeeland - Engels - Medsafe (Medicines Safety Authority)

ipca-escitalopram tablets

ipca pharma (nz) pty limited - escitalopram oxalate 12.74mg equivalent to escitalopram 10 mg;   - film coated tablet - 10 mg - active: escitalopram oxalate 12.74mg equivalent to escitalopram 10 mg   excipient: colloidal silicon dioxide croscarmellose sodium hypromellose macrogol 400 magnesium stearate microcrystalline cellulose purified talc   purified water titanium dioxide - in adults: treatment of major depression. treatment of social anxiety disorder (social phobia). treatment of generalised anxiety disorder. treatment of obsessive-compulsive disorder.